Close Menu

Phalanx Biotech

NEW YORK (GenomeWeb News) – Plexpress today announced it has partnered with Phalanx Biotech Group to offer a new service allowing researchers to discover, select, and validate biomarkers in a streamlined integrated workflow.

Phalanx Biotech has introduced its line of OneArray microRNA expression-profiling microarrays.

By Justin Petrone
Taiwanese array vendor Phalanx Biotech will launch a microarray for cytogenetics research in the second quarter, entering a market already dominated by Agilent Technologies, Affymetrix, and others.

Phalanx Biotech this week launched its OneArray microRNA expression profiling microarrays.

New Product Watch: Aug 30, 2011

Premium

Phalanx Biotech has updated its OneArray microRNA expression-profiling microarrays to reflect the content of miRBase version 17.

Phalanx Biotech has updated its OneArray microRNA-expression profiling microarrays.
The update adds 2,406 mature miRNAs and is based on an update to the University of Manchester's miRBase database of miRNAs.

New Product Watch: Jul 12, 2011

Premium

Affymetrix's Gene Profiling Reagents and Gene Profiling Array cGMP U133 P2, Phalanx Biotech's Rice Genome OneArray, CTGT's Connective Tissue Disorders Tests, Anagnostics' Hybcell DoA Saliva plexB-1-01 Array

The company, which runs facilities in Taiwan and California, is also considering adding next-generation sequencing services.

New Product Watch: Mar 22, 2011

Premium

Phalanx Biotech's Rat Whole Genome OneArray, Skyline Diagnostics' AMLprofiler

An Affy spokesperson said the firm's interest in the market is an extension of its gene-expression profiling play, and said several "key advantages" over rival tools could enable it to profit in the market, which is poised to grow 25 percent through 2015.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.